| Literature DB >> 29870523 |
Baijuan Xia1, Yixin Li1, Rongrong Li1, Dan Yin1, Xingqiang Chen1, Jie Li1, Wenmei Liang1.
Abstract
BACKGROUND Synaptic plasticity plays an important role in the process of addiction. This study investigated the relationship between synaptic plasticity and changes in addictive behavior and examined the expression of synaptic plasticity-associated proteins and genes in the nucleus accumbens (NAc) region in different rat models. MATERIAL AND METHODS Heroin addiction, SIRT1-overexpression, and SIRT1-silenced rat models were established. Polymerase chain reaction gene chip technology, immunohistochemistry, Western blotting, and transmission electron microscopy were used to detect changes in synaptic plasticity-related gene and protein expression, and changes in the ultrastructure of synapses, in the NAc. RESULTS Naloxone withdrawal symptoms appeared in the SIRT1-overexpression group. In the SIRT1-silenced group the symptoms were reduced. Immunohistochemistry and Western blotting results showed that FOXO1 expression decreased in the heroin addiction (HA) group but increased in the SIRT1-silenced group (p<0.05). The expression of Cdk5, Nf-κB, PSD95, and Syn was enhanced in the HA group (p<0.05) and further increased in the SIRT1-overexpression group but were reduced in the SIRT1-silenced group (p<0.05). The number of synapses increased in the HA group (p<0.05) along with mitochondrial swelling in the presynaptic membrane and obscuring of the synaptic cleft. CONCLUSIONS SIRT1 and other synaptic plasticity-related genes in NAc are involved in the regulation of heroin addiction. SIRT1 overexpression can increase behavioral sensitization in the NAc of rats, and SIRT1 silencing might ease withdrawal symptoms and reduce conditioned place preferences.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29870523 PMCID: PMC6016439 DOI: 10.12659/MSM.910550
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1Expression of pAAV-rSirt1-IRES-ZsGreen after transfection in the nucleus accumbens (NAc). (A) NAc of rats 1 week after virus transfection. (B) NAc of rats 2 weeks after virus transduction.
Figure 2SIRT1 expression after transduction of pAAV-rSirt1-IRES-ZsGreen into the nucleus accumbens.
Expression of synaptic plasticity-associated genes in the NAc of rats in the HA group compared with those in the SIRT1 overexpression group.
| Gene name | Description | Fractional up- or down-regulation |
|---|---|---|
| Activity-regulated cytoskeleton-associated protein | 4.50 ↑ | |
| Calcium/calmodulin-dependent protein kinase II alpha | 2.46 ↑ | |
| CCAAT/enhancer binding protein (C/EBP), delta | 2.32 ↑ | |
| Early growth response 1 | 2.88 ↑ | |
| Early growth response 2 | 4.14 ↑ | |
| Early growth response 3 | 3.96 ↑ | |
| Early growth response 4 | 2.39 ↑ | |
| Delta FBJ osteosarcoma oncogene B | 2.03 ↑ | |
| Mitogen activated protein kinase | 2.53 ↑ | |
| Nuclear receptor subfamily 4, group A, member 2 | 3.69 ↑ | |
| Glutamate receptor, ionotropic, AMPA 1 | 4.21 ↑ | |
| Glutamate receptor, ionotropic, AMPA 2 | 2.15 ↑ | |
| Glutamate receptor, metabotropic 3 | 2.54 ↑ | |
| Glutamate receptor, metabotropic 4 | 2.41 ↑ | |
| Inhibin beta-A | 2.07 ↑ | |
| Jun B proto-oncogene | 4.20 ↑ | |
| Nerve growth factor (beta polypeptide) | 2.32 ↑ | |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells | 2.18 ↑ | |
| Neuronal pentraxin 2 | 2.51 ↑ | |
| Pim-1 oncogene | 2.38 ↑ | |
| Protein phosphatase 3, catalytic subunit, alpha isoform | 2.36 ↑ | |
| brain derived neurotrophic factor | 0.28 ↓ | |
| Sirtuin (silent mating type information regulation 2 homolog) 1 | 2.38 ↑ |
↑ gene expression increase;
↓ gene expression decrease.
The expression of synaptic plasticity-associated genes in the NAc of rats overexpressing SIRT1 compared to controls.
| Gene name | Description | Fractional up- or down- regulation |
|---|---|---|
| Activity-regulated cytoskeleton-associated protein | 2.86 ↑ | |
| Calcium/calmodulin-dependent protein kinase II alpha | 2.09 ↑ | |
| Adenylate cyclase 8 (brain) | 0.44 ↓ | |
| Early growth response 1 | 3.02 ↑ | |
| Early growth response 2 | 4.37 ↑ | |
| Early growth response 3 | 2.77 ↑ | |
| Early growth response 4 | 2.15 ↑ | |
| Mitogen activated protein kinase 1 | 2.61 ↑ | |
| Nuclear receptor subfamily 4, group A, member 2 | 2.72 ↑ | |
| Glutamate receptor, ionotropic, AMPA 1 | 2.63 ↑ | |
| Glutamate receptor, ionotropic, AMPA2 | 2.32 ↑ | |
| Glutamate receptor, metabotropic 3 | 2.44 ↑ | |
| Glutamate receptor, metabotropic 4 | 2.13 ↑ | |
| Glutamate receptor, metabotropic 5 | 2.01 ↑ | |
| Delta FBJ osteosarcoma oncogene B | 2.47 ↑ | |
| Jun B proto-oncogene | 4.81 ↑ | |
| Kruppel-like factor 10 | 2.11 ↑ | |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells | 3.22 ↑ | |
| Matrix metallopeptidase 9 | 2.07 ↑ | |
| Neurotrophin 3 | 5.73 ↑ | |
| Protein phosphatase 1, regulatory (inhibitor) subunit 14A | 0.48 ↓ | |
| Serum response factor | 2.07 ↑ | |
| TIMP metallopeptidase inhibitor 1 | 0.41 ↓ | |
| Sirtuin (silent mating type information regulation 2 homolog) 1 | 6.28 ↑ |
↑ gene expression increase;
↓ gene expression decrease.
Comparison of naloxone-induced withdrawal symptoms among groups.
| Withdrawal signs | SC | HA | AAV-rSirt | AAV-Sirt1 ShRNA |
|---|---|---|---|---|
| Jumping | 2.8±0.84 | 3.4±1.14 | 3.6±1.14 | 3.2±0.837 |
| Rearing | 6.2±1.095 | 7.4±1.14 | 7.8±1.095 | 6.2±1.304 |
| Face washing | 3.2±0.837 | 10.6±2.074 | 12.2±1.304 | 7.6±1.342 |
| Wet dog shaking | 1.2±0.837 | 18±1.871 | 22.6±2.302 | 15.4±1.14 |
| Stretch | 1.6±0.548 | 7.2±1.483 | 7.2±1.304 | 5.4±1.14 |
| Teeth chatting | 2±0.707 | 6.6±1.949 | 8.6±1.14 | 5.6±0.894 |
| Blepharoptosis | None | With | With | With |
| Diarrhea | None | With | With | With |
P<0.05 compared with the SC group;
P<0.05 compared with the HA group.
Figure 3Length of stay of rats in the drug-associated chamber before and after training. # P<0.05 compared with the pre-training session; * P<0.05 compared with the heroin-addicted group.
Figure 4Cells positive for SIRT1, Cdk5, NF-κB, FOXO1, Cbp, and Syn in the NAc region (×400) and their optical density values (A) Saline control (SC) group; (B) Heroin-addicted (HA) group; (C) AAV-rSirt1 group; (D) AAV-rSirt1 shRNA group. # P<0.05 compared with the SC group; * P<0.05 compared with the HA group.
Figure 5Detection of SIRT1, Cdk5, FOXO1, NF-κB, Syn, and PSD95 protein levels in each group by immunoblotting. # P<0.05 compared with the saline control group; * P<0.05 compared with the HA group.
Figure 6Mitochondria (↑) and synapses (↓) in the nucleus accumbens of each group.
Figure 7(A–D) Ultrastructure of synapses in the nucleus accumbens region of each group.
Number of synapses and indices of synapse structures in the NAc region of rats.
| Group | Number of synapses | Index of synapse | |
|---|---|---|---|
| Thickness of synaptic cleft (nm) | Thickness of postsynaptic density (nm) | ||
| SCG | 4.5±0.35 | 15.38±2.27 | 42.82±5.37 |
| HAG | 6.73±1.02 | 19.34±3.68 | 48.07±4.51 |
| rSirt1 | 8.42±0.94 | 20.15±1.54 | 48.96±3.29 |
| rSirt1 ShRNA | 5.35±0.67 | 19.11±3.53 | 46.35±4.35 |
P<0.05 compared with the SC group;
P<0.05 compared with the HA group.